The Australian clinical trial that you mentioned is outlined here; Alzheimer's trial - Griffith University

It is confined to elderly subjects with late-onset Alzheimer’s Disease. Depending on its results, Etanercept might get regulatory approval here for treatment of Alzheimer’s Disease but I don't know about its possible role in treating hypoxic brain injury.